Fera announced the launch of sulfacetamide sodium ophthalmic ointment USP, 10%, an anti-infective ophthalmic agent. It is indicated for superficial ocular infections, including conjunctivitis. Sulfacetamide sodium is a sulfonamide bacteriostatic agent that inhibits the bacterial synthesis of folic acid by acting as both a competitive antagonist of para-aminobenzoic acid (PABA) as well as by inhibiting the enzyme dihydropteroate synthase which incorporates PABA into the folic acid precursor dihydropteroic acid.
Sulfacetamide sodium 10% is currently available as an ophthalmic solution.
For more information visit www.ferapharma.com.